?

Orloff John J

EVP, Research & Development
Alexion Pharmaceuticals, Inc.
US, Boston [HQ]
CIK 1643941

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.